Responding to a
report this morning about an imminent announcement on
funding for Pharmac, we have issued the following
comment:
Ah-Leen Rayner, chief executive of Breast
Cancer Foundation NZ, said: “This boost to Pharmac would
give breast cancer patients hope, since they were excluded
from the Government’s 13 promised drugs. There are two
treatments for incurable breast cancer on Pharmac’s Options
for Investment list – Keytruda and Enhertu – that are
proven to give women more time and it’s critical these are
both given a high priority so Kiwis can access them
urgently.
“$600m for Pharmac would certainly be a
good start to give immediate access to new cancer
treatments, and we also need to see a longer-term plan to
address Pharmac’s chronic underfunding and a model that
ensures women with breast cancer can have modern medicines
sooner.”
Advertisement – scroll to continue reading
© Scoop Media
Advertisement – scroll to continue reading